Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 4
    2
    50%
    Phase 1/2
    2
    50%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    2

    Late Stage

    Phase Distribution4 total trials
    Phase 1/2Combined phases
    2(50.0%)
    Phase 4Post-market surveillance
    2(50.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(2)
    Other(2)

    Detailed Status

    unknown2
    Completed2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 1/22 (50.0%)
    Phase 42 (50.0%)

    Trials by Status

    unknown250%
    completed250%

    Recent Activity

    0 active trials
    Showing 4 of 4
    unknownphase_4

    Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique

    NCT06337253
    completedphase_1_2

    Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

    NCT01319448
    completedphase_1_2

    Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)

    NCT01328990
    unknownphase_4

    Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal

    NCT00712374

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT06337253Phase 4

    Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique

    Unknown
    NCT01319448Phase 1/2

    Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

    Completed
    NCT01328990Phase 1/2

    Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)

    Completed
    NCT00712374Phase 4

    Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal

    Unknown

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4